Technology | May 20, 2011

Medrad Launches Second Generation Intego PET Infusion System


May 20, 2011 – Medrad Inc., a business of Bayer HealthCare, has announced the launch of the next generation Intego PET Infusion System, which features a new design that is 38% smaller, power-driven and includes enhancements to technologist workflow. The new Intego will be on display at the Annual Meeting of the Society of Nuclear Medicine (SNM), June 4-8, in San Antonio, Texas.

The Intego PET Infusion System, originally launched in 2008, remains the only FDA-cleared device for automated, controlled infusion of F18-FDG and F18-NaF, the most common PET diagnostic imaging agents used in oncology. Intego PET Infusion Systems have been sold throughout the world, including the United States, Latin America, South America, Europe, Africa, the Middle East, Asia and Australia.

For more information: www.medrad.com

Related Content

News | Contrast Media Injectors

May 3, 2016 — The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 ...

Home May 03, 2016
Home
Technology | Contrast Media Injectors

October 1, 2015 — Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline ...

Home October 01, 2015
Home
Feature | Contrast Media Injectors | Raissa Rocha and Dave Fornell

There have been several recent advances with contrast media injector technology, including cutting costs by reducing ...

Home February 10, 2015
Home
Feature | Contrast Media Injectors | Dave Fornell

Automated contrast media injectors are used in cardiac imaging to help improve patient safety and enhance image quality ...

Home July 08, 2010
Home
Subscribe Now